Table 1 The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease
Number | Percent | |
|---|---|---|
Age | 33.20 ± 8.6 | |
Sex | ||
Male | 36 | 45.0 |
Female | 44 | 55.0 |
Clinical features | ||
Duration of disease (years) | 4.6 ± 4.6 | |
Number of MS attacks/year | 2.75 ± 1.049 | |
Duration of last attack (months) | 3.3 ± 3 | |
Disability score (EDSS) | ||
No disability | 28 | 35.0 |
Minimal | 32 | 40.0 |
Moderate disability | 20 | 25.0 |
Disease modifying therapy (DMT) | ||
No | 52 | 65.0 |
Yes | 28 | 35.0 |
Male patients taking DMT | 16 | 44.4% |
Female patients taking DMT | 12 | 27.3% |
Symptomatic treatment | ||
No | 20 | 25.0 |
Yes | 60 | 75.0 |
Conventional MRI finding | ||
Number of plaques on T2 weighted images | 5.80 ± 3.421 | |
Black holes | 3.2 ± 2.3 | |
Enhanced plaques | 24 | 30.0 |
Non enhanced plaques | 56 | 70.0 |
Non-conventional MRI finding | ||
ADC | 1.37 ± 0.361 | |
NAA/Cr NAWM | 1.6 ± 0.40 | |
NAA/Cr plaque | 1.3 ± 0.46 | |
Cho/NAA NAWM | 0.67 ± 0.08 | |
Cho/NAA plaque | 0.72 ± 0.08 | |
Cho/Cr NAWM | 1.01 ± 0.30 | |
Cho/Cr plaque | 1.08 ± 0.31 |